184 related articles for article (PubMed ID: 38642556)
1. Modification of coronary artery disease clinical risk factors by coronary artery disease polygenic risk score.
Truong B; Ruan Y; Haidermota S; Patel A; Surakka I; Hornsby W; Koyama S; Lee SH; Natarajan P
Med; 2024 May; 5(5):459-468.e3. PubMed ID: 38642556
[TBL] [Abstract][Full Text] [Related]
2. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
[TBL] [Abstract][Full Text] [Related]
3. Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention.
Marston NA; Pirruccello JP; Melloni GEM; Koyama S; Kamanu FK; Weng LC; Roselli C; Kamatani Y; Komuro I; Aragam KG; Butterworth AS; Ito K; Lubitz SA; Ellinor PT; Sabatine MS; Ruff CT
JAMA Cardiol; 2023 Feb; 8(2):130-137. PubMed ID: 36576811
[TBL] [Abstract][Full Text] [Related]
4. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
Lu X; Liu Z; Cui Q; Liu F; Li J; Niu X; Shen C; Hu D; Huang K; Chen J; Xing X; Zhao Y; Lu F; Liu X; Cao J; Chen S; Ma H; Yu L; Wu X; Wu X; Li Y; Zhang H; Mo X; Zhao L; Huang J; Wang L; Wen W; Shu XO; Takeuchi F; Koh WP; Tai ES; Cheng CY; Wong TY; Chang X; Chan MY; Gao W; Zheng H; Chen K; Chen J; He J; Tang CS; Lam KSL; Tse HF; Cheung CYY; Takahashi A; Kubo M; Kato N; Terao C; Kamatani Y; Sham PC; Heng CK; Hu Z; Chen YE; Wu T; Shen H; Willer CJ; Gu D
Eur Heart J; 2022 May; 43(18):1702-1711. PubMed ID: 35195259
[TBL] [Abstract][Full Text] [Related]
5. Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke.
Kim J; Kim D; Bae HJ; Park BE; Kang TS; Lim SH; Lee SY; Chung YH; Ryu JW; Lee MY; Yang PS; Joung B
Cardiovasc Diabetol; 2024 Jan; 23(1):5. PubMed ID: 38172896
[TBL] [Abstract][Full Text] [Related]
6. Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.
Wünnemann F; Sin Lo K; Langford-Avelar A; Busseuil D; Dubé MP; Tardif JC; Lettre G
Circ Genom Precis Med; 2019 Jun; 12(6):e002481. PubMed ID: 31184202
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Lipoprotein(a) to Polygenic Risk Prediction of Coronary Artery Disease: A Prospective UK Biobank Analysis.
Manikpurage HD; Paulin A; Girard A; Eslami A; Mathieu P; Thériault S; Arsenault BJ
Circ Genom Precis Med; 2023 Oct; 16(5):470-477. PubMed ID: 37753708
[TBL] [Abstract][Full Text] [Related]
8. Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S;
Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731
[TBL] [Abstract][Full Text] [Related]
9. Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes.
Lu T; Forgetta V; Yu OHY; Mokry L; Gregory M; Thanassoulis G; Greenwood CMT; Richards JB
Cardiovasc Diabetol; 2020 Jan; 19(1):12. PubMed ID: 32000781
[TBL] [Abstract][Full Text] [Related]
10. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.
Aragam KG; Dobbyn A; Judy R; Chaffin M; Chaudhary K; Hindy G; Cagan A; Finneran P; Weng LC; Loos RJF; Nadkarni G; Cho JH; Kember RL; Baras A; Reid J; Overton J; Philippakis A; Ellinor PT; Weiss ST; Rader DJ; Lubitz SA; Smoller JW; Karlson EW; Khera AV; Kathiresan S; Do R; Damrauer SM; Natarajan P
J Am Coll Cardiol; 2020 Jun; 75(22):2769-2780. PubMed ID: 32498804
[TBL] [Abstract][Full Text] [Related]
11. European and US Guideline-Based Statin Eligibility, Genetically Predicted Coronary Artery Disease, and the Risk of Major Coronary Events.
Park H; Kim D; You SC; Jang E; Yu HT; Kim TH; Kim DM; Sung JH; Pak HN; Lee MH; Yang PS; Joung B
J Am Heart Assoc; 2024 May; 13(9):e032831. PubMed ID: 38639378
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program.
Vassy JL; Posner DC; Ho YL; Gagnon DR; Galloway A; Tanukonda V; Houghton SC; Madduri RK; McMahon BH; Tsao PS; Damrauer SM; O'Donnell CJ; Assimes TL; Casas JP; Gaziano JM; Pencina MJ; Sun YV; Cho K; Wilson PWF
JAMA Cardiol; 2023 Jun; 8(6):564-574. PubMed ID: 37133828
[TBL] [Abstract][Full Text] [Related]
13. Polygenic risk scores for coronary artery disease and subsequent event risk amongst established cases.
Howe LJ; Dudbridge F; Schmidt AF; Finan C; Denaxas S; Asselbergs FW; Hingorani AD; Patel RS
Hum Mol Genet; 2020 May; 29(8):1388-1395. PubMed ID: 32219344
[TBL] [Abstract][Full Text] [Related]
14. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
Li L; Pang S; Starnecker F; Mueller-Myhsok B; Schunkert H
Eur Heart J; 2024 May; 45(20):1843-1852. PubMed ID: 38551411
[TBL] [Abstract][Full Text] [Related]
15. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.
Inouye M; Abraham G; Nelson CP; Wood AM; Sweeting MJ; Dudbridge F; Lai FY; Kaptoge S; Brozynska M; Wang T; Ye S; Webb TR; Rutter MK; Tzoulaki I; Patel RS; Loos RJF; Keavney B; Hemingway H; Thompson J; Watkins H; Deloukas P; Di Angelantonio E; Butterworth AS; Danesh J; Samani NJ;
J Am Coll Cardiol; 2018 Oct; 72(16):1883-1893. PubMed ID: 30309464
[TBL] [Abstract][Full Text] [Related]
16. Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
Agbaedeng TA; Noubiap JJ; Mofo Mato EP; Chew DP; Figtree GA; Said MA; van der Harst P
Atherosclerosis; 2021 Sep; 333():48-55. PubMed ID: 34425527
[TBL] [Abstract][Full Text] [Related]
17. Associations between polygenic risk of coronary artery disease and type 2 diabetes, lifestyle, and cardiovascular mortality: A prospective UK Biobank study.
Yun JS; Jung SH; Shivakumar M; Xiao B; Khera AV; Park WY; Won HH; Kim D
Front Cardiovasc Med; 2022; 9():919374. PubMed ID: 36061534
[TBL] [Abstract][Full Text] [Related]
18. Reproducible disease phenotyping at scale: Example of coronary artery disease in UK Biobank.
Patel RS; Denaxas S; Howe LJ; Eggo RM; Shah AD; Allen NE; Danesh J; Hingorani A; Sudlow C; Hemingway H
PLoS One; 2022; 17(4):e0264828. PubMed ID: 35381005
[TBL] [Abstract][Full Text] [Related]
19. Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study.
Cho SMJ; Koyama S; Honigberg MC; Surakka I; Haidermota S; Ganesh S; Patel AP; Bhattacharya R; Lee H; Kim HC; Natarajan P
Eur Heart J; 2023 Sep; 44(36):3456-3465. PubMed ID: 37350734
[TBL] [Abstract][Full Text] [Related]
20. Assessing the performance of European-derived cardiometabolic polygenic risk scores in South-Asians and their interplay with family history.
Hassanin E; Maj C; Klinkhammer H; Krawitz P; May P; Bobbili DR
BMC Med Genomics; 2023 Jul; 16(1):164. PubMed ID: 37438803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
